Ameriprise Financial Inc Abiomed Inc Transaction History

Ameriprise Financial Inc

$381 Billion
Q3 2024

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$242.49 - $301.46 $873,206 - $1.09 Million	-3,601 Reduced 11.7%	27,173 $6.68 Million
Q2 2022 Aug 15, 2022	BUY	$224.73 - $338.64 $2.23 Million - $3.36 Million	9,918 Added 47.55%	30,774 $7.6 Million
Q1 2022 May 16, 2022	SELL	$277.25 - $366.29 $150 Million - $198 Million	-540,625 Reduced 96.29%	20,856 $6.88 Million
Q4 2021 Feb 14, 2022	SELL	$300.63 - $371.35 $8.37 Million - $10.3 Million	-27,853 Reduced 4.73%	561,481 $202 Million
Q3 2021 Nov 15, 2021	SELL	$310.19 - $376.2 $4.56 Million - $5.53 Million	-14,703 Reduced 2.43%	589,334 $192 Million
Q2 2021 Aug 16, 2021	SELL	$262.71 - $351.17 $3.25 Million - $4.34 Million	-12,366 Reduced 2.01%	604,037 $189 Million
Q1 2021 May 17, 2021	SELL	$285.92 - $355.13 $27 Million - $33.5 Million	-94,307 Reduced 13.27%	616,403 $196 Million
Q4 2020 Feb 12, 2021	BUY	$251.88 - $324.2 $36.8 Million - $47.4 Million	146,056 Added 25.87%	710,710 $230 Million
Q3 2020 Nov 16, 2020	SELL	$255.22 - $317.0 $69,675 - $86,541	-273 Reduced 0.05%	564,654 $156 Million
Q2 2020 Aug 14, 2020	SELL	$141.4 - $257.09 $2.46 Million - $4.47 Million	-17,372 Reduced 2.98%	564,927 $136 Million
Q1 2020 May 15, 2020	BUY	$130.51 - $196.01 $72.8 Million - $109 Million	558,142 Added 2310.48%	582,299 $84.5 Million
Q4 2019 Feb 14, 2020	BUY	$159.31 - $223.54 $224,308 - $314,744	1,408 Added 6.19%	24,157 $4.12 Million
Q3 2019 Nov 14, 2019	SELL	$175.89 - $279.23 $31 Million - $49.2 Million	-176,257 Reduced 88.57%	22,749 $4.05 Million
Q2 2019 Aug 14, 2019	SELL	$250.96 - $284.94 $5.32 Million - $6.04 Million	-21,180 Reduced 9.62%	199,006 $51.8 Million
Q1 2019 May 15, 2019	BUY	$276.39 - $362.25 $33.3 Million - $43.6 Million	120,451 Added 120.77%	220,186 $62.9 Million
Q4 2018 Feb 14, 2019	BUY	$281.08 - $444.25 $3.15 Million - $4.97 Million	11,195 Added 12.64%	99,735 $32.4 Million
Q3 2018 Nov 14, 2018	SELL	$354.53 - $449.75 $530,376 - $672,826	-1,496 Reduced 1.66%	88,540 $39.8 Million
Q2 2018 Aug 14, 2018	SELL	$278.07 - $446.21 $52.8 Million - $84.7 Million	-189,816 Reduced 67.83%	90,036 $36.9 Million
Q1 2018 May 15, 2018	BUY	$192.49 - $295.85 $30.9 Million - $47.5 Million	160,583 Added 134.64%	279,852 $81.4 Million
Q4 2017 Feb 12, 2018	SELL	$168.78 - $199.74 $17.7 Million - $21 Million	-105,042 Reduced 46.83%	119,269 $22.4 Million
Q3 2017 Nov 07, 2017	BUY	$145.39 - $168.6 $32.6 Million - $37.8 Million	224,311	224,311 $37.8 Million

Others Institutions Holding ABMD

# of Institutions

Shares Held

137K

Call Options Held

Put Options Held

View Full List

About ABIOMED INC

Ticker ABMD
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 45,460,900
Description
Abiomed, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It also provides a continuum of care to heart failure patients. The company offers Impella 2.5, a percutaneous micro heart pump with integrated motor and sensors; and Impella CP, a device for use by inte...

More about ABMD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ameriprise Financial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ameriprise Financial Inc with notifications on news.

Account